AzTrials
AzTrials

Risk Reduction Through Family TherapyRRFTNCT00998153

Risk Reduction for Drug Use and Sexual Revictimization

A study testing Risk Reduction through Family Therapy in people with Risk Reduction Through Family Therapy and Usual Care, run by Medical University of South Carolina at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigator proposes to evaluate Risk Reduction through Family Therapy (RRFT), which integrates: 1) an ecologically-based intervention for treatment of substance abuse behaviors in high risk adolescents, 2) exposure-based cognitive-behavioral therapy for sexually assaulted youth, and 3) psychoeducation strategies… Read more about this study

Who is it for?
Ages 12 to 17 years
What is being tested?
Risk Reduction through Family Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
135 participants
Where
1 siteUnited States
Study dates
1 Jul 2006to 30 Jun 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • memorable sexual assault

Who cannot join

  • active psychosis
  • active suicidality

Trial locations and contacts

1 site in 1 country.

United States1 site
  • National Crime Victims Research and Treatment Center

    Charleston, South Carolina, 29425

Other trials in United States

About this study

The investigator proposes to evaluate Risk Reduction through Family Therapy (RRFT), which integrates: 1) an ecologically-based intervention for treatment of substance abuse behaviors in high risk adolescents, 2) exposure-based cognitive-behavioral therapy for sexually assaulted youth, and 3) psychoeducation strategies for prevention of risky sexual behaviors and revictimization. The principal purpose of this research proposal is to evaluate the efficacy of RRFT in reducing the risk of drug abuse and other risky behaviors, PTSD, and revictimization among adolescents who have been sexually assaulted. The Research Plan will be conducted based on Stage 1a and Stage 1b from NIDA's Behavioral Therapies Development Program as described in Rounsaville, Carroll, \& Onken (2001). The final phase of the research will involve conducting a pilot randomized controlled trial of RRFT in a sample of adolescents, comparing primary outcome measures of youth receiving RRFT to youth receiving usual care in the community. Participants will be adolescents (12-17 years) who have experienced a sexual assault. Assessment of substance use and other risk behaviors, trauma-related psychopathology, and incidents of revictimization will be collected at pre- and post- treatment, as well as 6-week and 3-month follow-ups. Hierarchical Linear Modeling will be the primary method used to test study hypotheses. Development and evaluation of the proposed intervention will have significant implications for addressing public health problems in adolescent substance abuse and related high risk behaviors.

Read the detailed description

See above summary

Being tested
Risk Reduction through Family Therapy
Keywords
substance use, PTSD, risky behaviors, revictimization
Medical subject headings
Substance-Related Disorders, Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Risk Reduction through Family TherapyBehavioural

    Also called RRFT

    Component based intervention based on existing empirically supported treatments

Study groups in NCT00998153
Study groupRoleWhat they receive
1ExperimentalRRFT
Receives: Behavioral: Risk Reduction through Family Therapy
2Active comparatorUsual care
Receives: Behavioral: Risk Reduction through Family Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time Line Follow Back and urine screen

    Measured: Pre and post-treatment, 3 and 6 month follow-ups

Secondary outcomes (3)
  1. YRBS

    Measured: Pre and post-treatment, 3 and 6 month follow-ups

  2. FES

    Measured: Pre and post-treatment, 3 and 6 month follow-ups

  3. UCLA PTSD Reaction Index

    Measured: Pre, post, and 3 and 6 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Oct 2009 (estimated)
  2. Study start1 Jul 2006
  3. Primary completion30 Jun 2011
  4. Study completion30 Jun 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
135 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00998153
Sponsor's protocol ID
K23DA018686
Other IDs
K23DA018686
Acronym
RRFT
Status last verified
May 2018
First submitted
19 Oct 2009
Last updated
18 Jun 2018
Results posted
No
Data monitoring committee
Yes

Publications

  • Danielson CK, McCart MR, Walsh K, de Arellano MA, White D, Resnick HS. Reducing substance use risk and mental health problems among sexually assaulted adolescents: a pilot randomized controlled trial. J Fam Psychol. 2012 Aug;26(4):628-35. doi: 10.1037/a0028862. Epub 2012 Jun 11.

    PubMed 22686269

Questions about this trial

What is this clinical trial studying?

A study testing Risk Reduction through Family Therapy in people with Risk Reduction Through Family Therapy and Usual Care, run by Medical University of South Carolina at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time Line Follow Back and urine screen (time frame: Pre and post-treatment, 3 and 6 month follow-ups). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00998153, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in